David Auld - DR Horton President, Chief Executive Officer
| DHI Stock | USD 142.19 3.69 2.53% |
CEO
Mr. David V. Auld is President, Chief Executive Officer of the the Company. since October 2014. Mr. Auld was Executive Vice President and Chief Operating Officer from November 2013 through October 2014. Mr. Auld was Region President overseeing the Companys homebuilding operations in Florida, North and South Carolina, Georgia and Alabama from 2005 to 2013. From 1988 to 2005, Mr. Auld served as the Division President of the Company and its predecessors Orlando Division. Prior to 1988, Mr. Auld worked for Texas American Bank and General Dynamics since 2014.
| Age | 68 |
| Tenure | 10 years |
| Address | 1341 Horton Circle, Arlington, TX, United States, 76011 |
| Phone | 817 390 8200 |
| Web | https://www.drhorton.com |
DR Horton Management Efficiency
The company has Return on Asset of 0.1216 % which means that on every $100 spent on assets, it made $0.1216 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2166 %, implying that it generated $0.2166 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.37, while Return On Tangible Assets are projected to decrease to 0.05. As of now, DR Horton's Other Current Assets are increasing as compared to previous years. The DR Horton's current Total Current Assets is estimated to increase to about 34.8 B, while Intangible Assets are projected to decrease to under 9.5 M.Similar Executives
| Found 5 records | CEO Age | ||
| Stuart Miller | Lennar | 66 | |
| Paul Saville | NVR Inc | 68 | |
| Ryan Marshall | PulteGroup | 49 | |
| Richard Beckwitt | Lennar | 65 | |
| Jonathan Jaffe | Lennar | 64 | |
Management Performance
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.12 |
DR Horton Leadership Team
Elected by the shareholders, the DR Horton's board of directors comprises two types of representatives: DR Horton inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DHI. The board's role is to monitor DR Horton's management team and ensure that shareholders' interests are well served. DR Horton's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DR Horton's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Buchanan, Independent Director | ||
| Donald Horton, Executive Chairman of the Board | ||
| Maribess Miller, Independent Director | ||
| Michael Hewatt, Independent Director | ||
| Michael Murray, Co-Chief Operating Officer, Executive Vice President | ||
| Thomas Montano, Corporate VP | ||
| Aron Odom, Principal Accounting Officer | ||
| Jessica Hansen, VP of Communications | ||
| Barbara Allen, Independent Director | ||
| David Auld, President, Chief Executive Officer | ||
| Bill Wheat, Chief Financial Officer, Executive Vice President | ||
| Paul Romanowski, Co-Chief Operating Officer, Executive Vice President | ||
| Benjamin Carson, Independent Director | ||
| Collin Dawson, Vice Treasurer | ||
| Bradley Anderson, Independent Director | ||
| Matt Farris, President Region |
DHI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DR Horton a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 51.22 B | ||||
| Shares Outstanding | 330.2 M | ||||
| Shares Owned By Insiders | 9.80 % | ||||
| Shares Owned By Institutions | 85.04 % | ||||
| Number Of Shares Shorted | 4.99 M | ||||
| Price To Earning | 5.10 X |
Pair Trading with DR Horton
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DR Horton position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DR Horton will appreciate offsetting losses from the drop in the long position's value.Moving together with DHI Stock
| 0.86 | BC | Brunswick Earnings Call This Week | PairCorr |
Moving against DHI Stock
| 0.57 | NKE | Nike Inc Financial Report 4th of July 2024 | PairCorr |
| 0.52 | EGOX | NexteGO NV Ordinary | PairCorr |
| 0.51 | WINA | Winmark | PairCorr |
| 0.47 | VEEE | Twin Vee Powercats | PairCorr |
| 0.47 | EWCZ | European Wax Center Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to DR Horton could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DR Horton when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DR Horton - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DR Horton to buy it.
The correlation of DR Horton is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DR Horton moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DR Horton moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DR Horton can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.Note that the DR Horton information on this page should be used as a complementary analysis to other DR Horton's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for DHI Stock analysis
When running DR Horton's price analysis, check to measure DR Horton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DR Horton is operating at the current time. Most of DR Horton's value examination focuses on studying past and present price action to predict the probability of DR Horton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DR Horton's price. Additionally, you may evaluate how the addition of DR Horton to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |
Is DR Horton's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.022 | Dividend Share 1.05 | Earnings Share 13.87 | Revenue Per Share 106.305 | Quarterly Revenue Growth 0.065 |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.